Cohance Lifesciences Limited

SBI Mutual Fund took a new position in Cohance Lifesciences, acquiring 1,27,34,835 shares worth ₹560.77 crore for a 3.33% stake. The share price was ₹441.90.

A Hyderabad-based contract development and manufacturing organization serving leading global pharmaceutical and fine chemical companies. Cohance Life provides integrated services spanning process research and development through late-stage clinical and commercial manufacturing for new chemical entities. The company distinguishes itself through its commitment to delivering customized solutions that fulfill specific customer needs and expectations across the entire drug development lifecycle.

India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.